Benitec Biopharma Inc. Annual report pursuant to Section 13 and 15(d)

Loss per share (Tables)

12 Months Ended

Jun. 30, 2023


	Year Ended June 30,
	2022			2022
Net loss attributable to common stockholders (US$’000)	($	19,562	)	($	18,208	)
Weighted average number of shares used in calculating basic and diluted earnings per share		1,385,818			480,688

Basic and diluted loss per share	($	14.12	)	($	37.88	)